# Vishuo Biomedical Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vishuo-biomedical-pte

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Website: www.vishuo.com
- Total disclosed funding: $6.5M
- Latest round: Series A (Jun 1, 2015)
- Investors on record: 2

## About

Established in 2014 and based in Singapore, Vishuo Biomedical is a biomedical company that focuses on establishing a precision medical platform for the diagnosis and treatment of various diseases. In June 2015, Vishuo Biomedical raised RMB 40 million in series A funding from Anjie Investment and Anlongmed Investment. In August 2017, Vishuo Biomedical raised funding from Anlongmed Investment.

The products developed by the company include  iCMDB® knowledgebase, Clair-One-Stop Pharmacogenomics Solution, Origo™ precision oncology platform, disease risk prediction. The company also provides a BioLIMS, which is a Laboratory Information Management System (LIMS) designed for the operations of a running laboratory. It helps in organizing and keeping track of clinical samples, and correlating patient data with their respective experimental data and reports.

## Funding rounds

- Series A, Jun 1, 2015, $6.5M — AnlongMed Investment, Anjie Investment

## Investors

- AnlongMed Investment — Series A
- Anjie Investment — Series A